Published on 15 Aug 2022 on Zacks via Yahoo Finance
Nemaura Medical, Inc. (NMRD) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.14 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -6.25%. A quarter ago, it was expected that this company would post a loss of $0.15 per share when it actually produced a loss of $0.15, delivering no surprise.
Over the last four quarters, the company has not been able to surpass consensus EPS estimates.